Microbiology Testing/Clinical Microbiology Market - Industry Analysis, Market Size, Share, Trends, Growth And Forecast 2020 - 2025
Clinical Microbiology Market Overview
Clinical Microbiology Market size is estimated to reach $5.58bn by 2025, growing at a CAGR of 6.35% during the forecast period 2020-2025. Clinical microbiology is a discipline that incorporates with the testing for microorganisms. It is focused on medical science which is concerned with the prevention, diagnosis, and treatment of infectious diseases. The clinical microbiology is used for the rapid identification of the microorganism and for the treatment of the infectious diseases caused by bacteria, fungus, viruses, parasites and another microorganism. Clinical microbiology market is set to grow significantly in the coming years, owing to the key factors such as rise in hospital-acquired infection & fungal infections in the immune-compromised and pathogen discovery across the globe. The technological advancements in disease diagnostics, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments in the field of disease diagnosis are set to drive the market in the forecast period 2020-2025.
Clinical Microbiology Market Report Coverage
The report: “Clinical Microbiology Market Forecast (2020-2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Clinical Microbiology Market.
By Product: Instruments and Reagents.
By Indication: Respiratory Diseases, Bloodstream Infections, Pharmaceutical Applications, Gastrointestinal Diseases, Sexually Transmitted Diseases, Periodontal Diseases, Urinary Tract Infections, and other Indications.
By End User: Hospitals & Diagnostic Centres, Custom Lab Service Providers, and Academic & Research Institutes.
By Application: Food Testing Applications, Clinical Applications, Energy Applications, Chemical & Material Manufacturing Applications, And Environmental Applications.
By Geography: North America, Asia-Pacific, Europe, and Rest of World
- Geographically, North America’s Clinical Microbiology market accounted for the highest revenue share in 2019 and it is poised to dominate during the forecast period 2020-2025 owing to the high number of registered treatments and increasing use of cartilage repair or regeneration to treat injuries.
- Rising technological advancements in the diagnostics have helped in significant growth of clinical microbiology market.
- Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Clinical Microbiology Market report.
- Lack of adequate skilled and well-trained workforce on handling the pathogenic microorganisms are anticipated to hamper the market growth of the clinical microbiology market.
By Indication - Segment Analysis
The global clinical microbiology market based on indication has respiratory diseases, bloodstream infections (BSIs), gastrointestinal (GI) diseases, sexually transmitted diseases (STDs), urinary tract infections (UTIs), periodontal diseases, and other diseases (including cardiovascular disease, central nervous system infections, connective tissue & joint diseases, and skin diseases). The respiratory disease segment registers for highest market share in 2019 and is set to continue for the forecast period (2020-2025). The segment is set to emerge owing to the large patient population suffering from respiratory diseases, rising prevalence of target respiratory diseases (including bronchitis, TB, asthma, COPD, and) across developing countries, and increasing number of epidemic outbreaks of respiratory infections.
By Application - Segment Analysis
The global clinical microbiology market based on applications has clinical, food testing, energy, pharmaceutical, chemical & material manufacturing, and environmental applications. The pharmaceutical applications segment registers for the highest market share in 2019 and is set to continue for the forecast period 2020-2025, owing to the presence of globally accepted regulations in pharmaceutical manufacturing and raw material sourcing processes.
By Geography - Segment Analysis
The global Clinical Microbiology Market by geography had the dominant share in North America in terms of revenue in 2019 owing to the high number of registered treatments and increasing use of cartilage repair or regeneration to treat sports injuries and other accidents. Europe comes in second in terms of market share owing to the rising awareness about blood related disorders and swift availability of treatment in terms of plasma fractionation. However, Asia-Pacific is estimated to outpace all the regions by clocking the highest CAGR during the forecast period 2020-2025 owing to the rising number of hospitals and clinical diagnostic laboratories.
Drivers – Clinical Microbiology Market
- Increased rate of infectious diseases and advancements in the technology
The demand for Clinical Microbiology is driving forward owing to the increase in the awareness about early infection to avoid risks. Clinical microbiology uses a number of rapid tests to detect specific bacterial antigen in non-histopathological primary specimens that help to identify infection faster. This is driving the market growth. Besides, many microbial laboratories have implemented automation to process the detection and isolation of a specific microorganism are acting as drivers for supporting the growth of the clinical microbiology market.
Challenges – Clinical Microbiology Market
- Lack of skilled workforce and high cost equipment
Clinical Microbiology requires a well-trained and skilled workforce as it needs to deal with pathogenic microorganisms. The equipment used in this test is expensive and difficult to handle, which is estimated to impede the growth of the clinical microbiology market.Strict rules by the government in approving new products has become a challenge for the growth of market for the forecast period 2020-2025.
Clinical Microbiology Industry outlook:
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Clinical Microbiology Market. Key companies of this market are Thermo Fisher Scientific, Sigma-Aldrich Corporation, Danaher Corporation, Merck KGaA, Bio-Rad Laboratories, Inc, bioMerieux Inc., QIAGEN N.V, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Siemens Healthineers AG.
- In June 2020, Hoowaki LLC develops a one-piece injection moulded design for the COVID-19 swabs.
- In October 2019, Microbiologics Inc announced that it acquired Micromyx to develop new antimicrobial agents for clients in the pharmaceutical, biotechnology and animal health industries.
1. Clinical Microbiology Market Overview
1.1 Definitions and Scope
2. Clinical Microbiology Market - Executive Summary
2.1 Market Revenue and Key Trends by Company
2.2 Key trends by Product
2.3 Key trends by Indication
2.4 Key trends by End User
2.5 Key trends by Application
2.6 Key trends by Geography
3. Clinical Microbiology Market – Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split by Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis
4. Clinical Microbiology Market - Startup Companies Scenario Premium
4.1 Key Startup Company Analysis by
4.1.3 Venture Capital and Funding Scenario
5. Clinical Microbiology Market – Industry Market Entry Scenario Premium Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case Studies of Successful Ventures
6. Clinical Microbiology - Market Forces
6.1 Market Drivers
6.2 Market Constraints/Challenges
6.3 Porters five force model
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7. Clinical Microbiology Market – Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle
8. Clinical Microbiology Market – By Product (Market Size –$Million/$Billion)
8.2.1 Laboratory Instruments
126.96.36.199 Gram Stainers
188.8.131.52 Bacterial Colony Counters
184.108.40.206 Autoclave Sterilizers
220.127.116.11 Microbial Air Samplers
18.104.22.168 Anaerobic Culture Systems
22.214.171.124 Petri Dish Fillers
126.96.36.199 Blood Culture Systems
188.8.131.52 Microbial Culture Systems
184.108.40.206 Other Laboratory Instruments
8.2.2 Microbiology Analyzers
220.127.116.11 Molecular Diagnostic Instruments
18.104.22.168 Mass Spectrometers
8.3.1 Pathogen-Specific Kits
8.3.2 General Reagents
9. Clinical Microbiology Market - By Indication (Market Size – $Million/$Billion)
9.2 Respiratory Diseases
9.3 Bloodstream Infections
9.4 Gastrointestinal Diseases
9.5 Sexually Transmitted Diseases
9.6 Urinary Tract Infections
9.7 Periodontal Diseases
9.8 Other Indications
10. Clinical Microbiology Market - By End User (Market Size – $Million/$Billion)
10.2 Hospitals & Diagnostic Centers
10.3 Custom Lab Service Providers
10.4 Academic & Research Institutes
11. Clinical Microbiology Market - By Application (Market Size – $Million/$Billion)
11.2 Pharmaceutical Applications
11.3 Food Testing Applications
11.4 Clinical Applications
11.5 Energy Applications
11.6 Chemical & Material Manufacturing Applications
11.7 Environmental Applications
12. Clinical Microbiology Market - By Geography (Market Size – $Million/$Billion)
12.1 North America
12.2.6 Rest of Europe
12.3.4 South Korea
12.3.5 Australia & New Zealand
12.3.6 Rest of Asia-Pacific
12.4 Rest of the World
12.4.1 Middle East
12.4.3 South America
13. Clinical Microbiology Market - Entropy
14. Clinical Microbiology Market – Industry/Segment Competition Landscape Premium
14.1 Market Share Analysis
14.1.1 Global Market Share – Key Companies
14.1.2 Market Share by Region – Key companies
14.1.3 Market Share by Countries – Key Companies
14.1.4 Best Practices for Companies
15. Clinical Microbiology Market – Key Company List by Country Premium Premium
16. Clinical Microbiology Market Company Analysis
16.1 Company 1
16.2 Company 2
16.3 Company 3
16.4 Company 4
16.5 Company 5
16.6 Company 6
16.7 Company 7
16.8 Company 8
16.9 Company 9
16.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.